INTRODUCTION
============

In response to hypoxia, cells express several genes to maintain homeostasis. More than 500 genes, including vascular endothelial growth factor (*VEGF*), erythropoietin (*EPO*), phosphoglycerate kinase-1 (*PGK-1*), glucose transporter-1 (*glut-1*), and BCL-2/adenovirus E1B 19 kDa interacting protein 3 (*Bnip3*) are induced under hypoxia in MCF7 cells ([@b12-molcell-37-1-43-7]). These diverse target genes are transcribed by a common transactivator, the hypoxia-inducible factor 1-α/β (HIF-1α/β) heterodimer ([@b27-molcell-37-1-43-7]). Under normoxic conditions, HIF-1α is ubiquitinated and rapidly degraded whereas HIF-1β is constitutively expressed. HIF-1β is identical to the Aryl hydrocarbon receptor nuclear translocator (Arnt) that is a dimerization partner protein of the dioxin receptor, Aryl hydrocarbon receptor. The 403^rd^ and 564^th^ proline residues of human HIF-1α are hydroxylated by prolyl hydroxylase domain protein (PHD) ([@b6-molcell-37-1-43-7]). The hydroxylated prolines are recognized by the E3 ubiquitin ligase von Hippel-Lindau protein (pVHL), which triggers the ubiquitination-dependent degradation of HIF-1α ([@b21-molcell-37-1-43-7]). The 803^rd^ asparagine residue of HIF-1α is also hydroxylated by an oxygen-dependent asparagine hydroxylase, referred to as Factor-Inhibiting HIF-1 (FIH-1). The hydroxylated asparagine residue hinders the recruitment of the CREB-binding protein (CBP)/p300 coactivator. PHD and FIH-1 require molecular oxygen, α-ketoglutarate, vitamin C, and Fe(II) for their catalytic activities. The trans-active form of HIF-1α is stabilized under hypoxia because the activities of these two oxygen-dependent hydroxylases decrease ([@b15-molcell-37-1-43-7]).

FIH-1 has unique structural and catalytic properties compared to PHD ([@b16-molcell-37-1-43-7]). The catalytic region of FIH-1 (145--340 amino acids in human FIH-1) shows structural similarity to the Jumonji (Jmj) domain, which is often found in histone demethylases ([@b8-molcell-37-1-43-7]; [@b20-molcell-37-1-43-7]). JmjC domain containing proteins (JMJDs) catalyze the oxidative demethylation of a methylated lysine residue of histones. Although JMJDs and FIH-1 hydroxylate different target proteins, both utilize O~2~, α-ketoglutarate, vitamin C, and Fe(II) and produce succinate and CO~2~.

More than 100 JMJDs have been identified, and most of them have demethylase activity with different substrate specificities ([@b28-molcell-37-1-43-7]). JMJD1A/JHDM2A/KDM3A demethylate H3K9me2 and me1, JMJD2 isozymes demethylate H3K9me3, Jarid1 isozymes demethylate H3K4me3, and JMJD3/KDM6B demethylate H3K27me3. Histone methylation affects gene expression in distinct localized patterns. The tri-methylation of H3K4 and acetylation of H3 in the promoter region are associated with actively transcribed genes, whereas the methylation of H3K9 and H3K27 in the promoter region are associated with inactive genes ([@b18-molcell-37-1-43-7]). The fact that JmjC proteins need molecular oxygen for their catalytic activities suggests that their activities can be inhibited under hypoxic conditions. Recent findings that hypoxia induced several JmjC proteins imply that their induction compensates their reduced catalytic activity under hypoxia ([@b5-molcell-37-1-43-7]; [@b25-molcell-37-1-43-7]; [@b29-molcell-37-1-43-7]; [@b31-molcell-37-1-43-7]). Thus, in response to hypoxic stress, histone methylation of individual genes can be dynamically regulated by the net change in the activity and expression of the JmjC proteins.

JMJD2s, JMJD1A, and Jarid1B have been identified as HIF-1α target genes ([@b5-molcell-37-1-43-7]; [@b25-molcell-37-1-43-7]; [@b31-molcell-37-1-43-7]). This study first demonstrated that hypoxia also induces an H3K27me3 demethylase, JMJD3, by a HIF-1α dependent mechanism. Together with the recent findings that JMJD3 is involved in inflammation, cardiac development, neural development, and senescence, this study suggests that hypoxia can influence these diverse biological processes by changing the expression level of JMJD3.

MATERIALS AND METHODS
=====================

Cell culture, reagents, and antibodies
--------------------------------------

Human adipose-derived stem cells (hADSC, R7788-115), which are isolated from human adipose tissue collected during liposuction procedures, were purchased from Life technology (USA). Cells were plated in a 100-mm plate at a density of 5,000 cells/cm^2^ in DMEM supplemented with 10% mesenchymal stem cell (MSC)-qualified fetal bovine serum (FBS). Wild-type mouse embryonic fibroblasts (MEFs) were prepared from 13.5 post-coitum (p.c.) embryos of C57BL/6 background and maintained in DMEM supplemented with 10% FBS by using the 3T3 protocol until reaching passage 7. The other mouse cells were maintained as described previously ([@b10-molcell-37-1-43-7]; [@b24-molcell-37-1-43-7]). For hypoxic treatments, cells were cultured in an anaerobic incubator (\< 0.5% O~2~, Model 1029, Forma Scientific, Inc.) or in InVivo~2~ 200 hypoxia workstation (3% O~2~, Ruskin). Deferoxamine (DFN), cobalt chloride (CoCl~2~), and Clioquinol (CQ) were purchased from Sigma-Aldrich (USA). Antibodies against mouse and human JMJD3 were purchased from Abgent (USA) and Abcam (UK), respectively. Anti-mouse and human HIF-1α antibodies were purchased from Novus Biologicals (Littleton, CO) and BD Biosciences (USA), respectively. Anti-HSP70 and anti-β-Actin antibodies were obtained from Enzo Life Sciences (USA) and Sigma-Aldrich, respectively. Anti-Arnt and anti-H3K4 me3 antibodies were obtained from Cell Signaling Technology (USA). Antibodies against H3K9me3, H3K27me3, H3K9/K14Ac, and 14-3-3γ were purchased from Millipore (USA).

RNA isolation and quantitative real-time PCR
--------------------------------------------

Total RNA was isolated using an RNeasy spin column according to the manufacturer's instructions (Qiagen Inc., USA). cDNA was reverse transcribed from total RNA (2 μg) using M-MLV reverse transcriptase (Promega, USA) with dNTPs and random primers. The qRT-PCR analyses were performed by using the Power SYBR Green PCR Master Mix and ABI 7000 Real-Time PCR System (Applied Biosystems) for MEFs experiments and all hADSC experiments. The iQ™ SYBR Green Supermix and MyiQ single color real-time PCR detection system (Bio-Rad, USA) were used for the analyses of the RNA from the other mouse cells including 3T3-L1 cells, NIH-3T3 cells, Hepa1c1c7 cells, and BpRC1 cells. The primer sets for JMJD3 were following: mJMJD3, (F) 5′-CCC CCA TTT CAG CTG ACT AA-3′, (R) 5′-CTG GAC CAA GGG GTG TGT T-3′, for [Figs. 1A](#f1-molcell-37-1-43-7){ref-type="fig"}, [1B](#f1-molcell-37-1-43-7){ref-type="fig"}, [1D](#f1-molcell-37-1-43-7){ref-type="fig"} and [2B](#f2-molcell-37-1-43-7){ref-type="fig"} ([@b11-molcell-37-1-43-7]); mJMJD3, (F) 5′-CCT GCA GTC AAT GAA GCA CTG-3′, (R) 5′-CTC CAC GTC GCA TTC GTT G-3′, for [Figs. 1C](#f1-molcell-37-1-43-7){ref-type="fig"} and [1G](#f1-molcell-37-1-43-7){ref-type="fig"}; hJMJD3, (F) 5′-GGA GGC CAC ACG CTG CTA C-3′, (R) 5′-GCC AGT ATG AAA GTT CCA GAG CTG-3′. The primer sets for other genes were previously described ([@b10-molcell-37-1-43-7]; [@b13-molcell-37-1-43-7]).

Chromatin Immunoprecipitation
-----------------------------

ChIP analyses were performed as described previously with the following modifications ([@b14-molcell-37-1-43-7]; [@b22-molcell-37-1-43-7]). Briefly, hADSC, 3T3-L1, and MEF cells were cross-linked in 1% formaldehyde at 37°C for 10 min, and then the nuclei were isolated ([@b19-molcell-37-1-43-7]). The isolated nuclei of hADSC and 3T3-L1 cells were treated with MNase (300 gel units) for 15 min, and sonicated to shear the chromatin ([@b30-molcell-37-1-43-7]). The insoluble materials were removed by centrifugation at 10,000 × *g* for 10 min. We measured the DNA concentration of the supernatant containing soluble chromatin to ensure that the amount of chromatin used in each sample was similar. For each immunoprecipitation, 30--40 μg of soluble chromatin was 10-fold diluted with ChIP dilution buffer \[20 mM Tris-HCl (pH 8.0), 0.01% SDS, 1% Triton X-100, 2 mM EDTA, 150 mM NaCl\]. The diluted lysates of soluble chromatin (100 μl) were analyzed using qPCR and the resulting quantitative values were used as input. The diluted lysates (1 ml) were immunoprecipitated with 2--4 μg of the indicated antibodies at 4°C overnight. The antibody-chromatin complexes were recovered by incubation with 20 μl of protein G-agarose (50% slurry) and sequentially washed as described previously ([@b22-molcell-37-1-43-7]). The immuno-complexes were eluted with 150 μl of elution buffer (1% SDS, 0.1 M NaHCO~3~) and reversed. Target DNA from 3 μl sample were analyzed by PCR. The ChIP primer sets for putative HREs located at upstream and first intron of the *JMJD3* gene are following ; m*JMJD3* −0.2 kb, (F) 5′-TGG GCC TGA GCC AGA ATA-3′, (R) 5′-AGC AGC CTG GTT CAG GTA GTA A-3′; m*JMJD3* +4.2 kb, (F) 5′-TGC GCA AGT AGC CAC GTC A-3′, (R) 5′-TCC TGT ATC CTC TGT GCC CTT T-3′; h*JMJD3* −4.1 kb, (F) 5′-ACG TGC ACT CCC ACA CGC T-3′, (R) 5′-CAC AGA CTC CAC GAG GGG AG-3′; h*JMJD3* −3.3 kb, (F) 5′-GGG GAT CCT GCA GAT GGA AG-3′, (R) 5′-ACA TTT CTG ACG GGA GTC GG-3′; h*JMJD3* +1.9 kb, (F) 5′-AAG AAG CGA GCG TGT AAC CC-3′, (R) 5′-GAG CCC GCA GAT AGG GTT TT-3′; h*JMJD3* +3.3 kb, (F) 5′-CTG ATG GAA AGG ATG CTG CC-3′, (R) 5′-ATG GAA GCG CTT GGA CCC TA-3′; h*JMJD3* +4.1 kb, (F) 5′-CAT TTA CAC ACA CCG CTT CCG-3′, (R) 5′-TGG CTC GCG TAT CCT CTC T-3′. The ChIP primer sets for the other genes were described previously ([@b23-molcell-37-1-43-7]).

*sh*RNA mediated knock-down
---------------------------

HIF-1α was knocked down using a retrovirus infection system, pSIREN-RetroQ (BD Biosciences), as described previously ([@b22-molcell-37-1-43-7]). The short hairpin RNA (*sh*RNA) sequence against mouse HIF-1α was 5′-TGT GAG CTC ACA TCT TGA TT-3′.

RESULTS
=======

Hypoxia induced JMJD3 in HIF-1α-dependent manner
------------------------------------------------

We found that hypoxia increased the expression of JMJD3 in several types of cells including mouse fibroblast NIH3T3 cells, mouse preadipocytes 3T3-L1 cells, and MEFs ([Figs. 1A](#f1-molcell-37-1-43-7){ref-type="fig"}--[1C](#f1-molcell-37-1-43-7){ref-type="fig"}). In order to test whether hypoxia increased the expression of JMJD3 in HIF-1α-dependent manner, we used mouse 3T3-L1 cells infected with a retrovirus encoding *sh*RNA against mouse HIF-1α. The qRT-PCR analyses confirmed that the mRNA levels of either HIF-1α or its target Bnip3 were reduced in the HIF-1α knockdown 3T3-L1 (*sh*HIF-1α 3T3-L1) cells ([Fig. 1D](#f1-molcell-37-1-43-7){ref-type="fig"}). Hypoxia failed to induce JMJD3 mRNA in *sh*HIF-1α 3T3-L1 cells. Western analyses also confirmed that hypoxia stabilized HIF-1α protein in *sh*Control 3T3-L1 cells but not in *sh*HIF-1α 3T3-L1 cells, and that hypoxia failed to increase the levels of JMJD3 protein in *sh*HIF-1α 3T3-L1 cells ([Fig. 1E](#f1-molcell-37-1-43-7){ref-type="fig"}). HIF-1α protein was stabilized by nonhypoxic mimickers such as deferoxamine (DFN) and CoCl~2~ that inhibit the prolyl hydroxylation-dependent ubiquitination of HIF-1α ([Fig. 1F](#f1-molcell-37-1-43-7){ref-type="fig"}). We also showed that not only hypoxia but also nonhypoxic HIF-1α activators induce JMJD3 ([Fig. 1G](#f1-molcell-37-1-43-7){ref-type="fig"}).

Hypoxia induced JMJD3 in Arnt-dependent manner
----------------------------------------------

The heterodimerization with Arnt is a prerequisite for HIF-1α to interact with the hypoxia-responsive elements (HRE). In order to test whether Arnt is also required for the hypoxic induction of JMJD3, we used BpRC1 cells which are Arnt-defective variants of mouse hepa1c1c7 cells ([@b17-molcell-37-1-43-7]). Western analyses revealed that Arnt protein is constitutively expressed in wild type hepa1c1c7 cells but not in BpRC1 cells ([Fig. 2A](#f2-molcell-37-1-43-7){ref-type="fig"}). We found that hypoxia failed to induce the mRNA of JMJD3 in Arnt-defective hepa1c1c7 variant cells ([Fig. 2B](#f2-molcell-37-1-43-7){ref-type="fig"}). These findings indicated that hypoxia induced JMJD3 in an HIF-1α/Arnt-dependent mechanism. In macrophages, transcription of mouse JMJD3 was driven by the promoter located in the first intron ([@b11-molcell-37-1-43-7]). By using the MatInspector program, we found HRE consensus sequences in the upstream and the first intron of the mouse *JMJD3* gene ([Fig. 2C](#f2-molcell-37-1-43-7){ref-type="fig"}) ([@b7-molcell-37-1-43-7]). In order to test whether HIF-1 occupies HREs in the *JMJD3* gene, we performed ChIP analyses using the HIF-1α antibody. We confirmed that HIF-1α binds to its target gene *Stra13*. According to the ChIP analyses, HIF-1α was detected in the first intron rather than in the upstream region of mouse *JMJD3* gene in hypoxic 3T3-L1 cells ([Fig. 2D](#f2-molcell-37-1-43-7){ref-type="fig"}). ChIP analyses using an antibody against the 9th and 14th acetylated residues of histone 3 (H3K9/K14Ac) revealed that hypoxia increases the transactive histone maker, H3K9/K14Ac, in both *JMJD3* and *Stra13* genes. We also found the HIF-1α occupancy on the first intron of *JMJD3* in hypoxic MEFs. Additionally, we showed that 3% oxygen slightly increases HIF-1α occupancy on both *JMJD3* and *Stra13* ([Fig. 2E](#f2-molcell-37-1-43-7){ref-type="fig"}).

Hypoxic induction of human JMJD3 in hADSC
-----------------------------------------

We tested whether hypoxia induces JMJD3 expression in human cells. qRT-PCR analyses revealed that hypoxia increased the mRNA levels of JMJD3 in hADSC. Clioquinol, an HIF-1α activator, also induced JMJD3 in these cells ([Fig. 3A](#f3-molcell-37-1-43-7){ref-type="fig"}). Previous findings showed that Clioquinol inhibits the asparaginyl hydroxylation activity of FIH-1 and also the prolyl hydroxylation-dependent ubiquitination of HIF-1α, thus Clioquinol stabilized the transactive form of HIF-1α protein even under normoxia ([@b9-molcell-37-1-43-7]). We confirmed that Clioquinol also increased both the mRNA and protein levels of human JMJD3 in hADSC ([Fig. 3B](#f3-molcell-37-1-43-7){ref-type="fig"}). We also found several HREs located in both upstream and the first intron of the human *JMJD3* gene ([Fig. 3C](#f3-molcell-37-1-43-7){ref-type="fig"}) ([@b7-molcell-37-1-43-7]). Differently from mouse *JMJD3*, in hADSC, ChIP analyses revealed that both HIF-1α and Arnt bind HREs in the upstream region rather than on the first intron of human *JMJD3* ([Figs. 4A](#f4-molcell-37-1-43-7){ref-type="fig"}--[4D](#f4-molcell-37-1-43-7){ref-type="fig"}). In order to detect any change of histone mark in the upstream region of human *JMJD3*, we performed ChIP analyses using antibodies detecting the methylation and acetylation of histone 3. We found that repressive histone marks such as H3K9me3 and H3K27me3 were maintained at undetectable low level in the upstream of the human *JMJD3* gene, while hypoxia and Clioquinol increased the active histone marks H3K4me3 and H3K9/K14Ac ([Figs. 4E](#f4-molcell-37-1-43-7){ref-type="fig"}--[4F](#f4-molcell-37-1-43-7){ref-type="fig"}).

DISCUSSION
==========

In this study, we showed that hypoxia induced the expression of JMJD3 in an HIF-1α-dependent manner, and that the presence of Clioquinol, an HIF-1α activator, increased JMJD3 expression even under normoxia. ChIP analyses showed that both HIF-1α and HIF-1β/Arnt bound to the first intron region of the mouse *JMJD3* gene, but to the upstream region of the human *JMJD3*, indicating that human and mouse *JMJD3* have hypoxia regulatory regions in different locations. HIF-1α binding sites are often found far from the transcription start sites. In *ARRDC3* and *ERRFI1* genes, HREs are located around −100 kb from the transcription start sites and activate the transcription ([@b26-molcell-37-1-43-7]). HIF-1α binds HREs in open chromatin region of which H3K4 residues are tri-methylated ([@b31-molcell-37-1-43-7]). Consistently, our results indicated that HIF-1α bound to chromatin region of human JMJD3 gene which has a high level of H3K4me3.

The fact that JMJD3 uses molecular oxygen as a substrate suggests that the catalytic activity of JMJD3 can be inhibited under hypoxia. Interestingly, many hydroxylases, including collagen-prolyl hydroxylase and the H3K9me2 demethylase JMJD1A, maintain their catalytic activities even under severe hypoxia, because their *K*~m~ values for O~2~ are very low. The *K*~m~ value for O~2~ associated with JMJD3 remains to be estimated. The facts that HIF-1 can be activated by nonhypoxic signals such as mTOR pathways, oxidative stresses, and inflammatory signals, and that HIF-1 increases JMJD3 expression suggest that some of the nonhypoxic HIF-1-activating stimuli can increase the amounts of JMJD3 without reducing its catalytic activity. The biological importance of JMJD3 primarily relies on the function of its target genes. Since histone modifiers such as histone methyltransferase and demethylases do not have the ability to recognize specific DNA sequences, the targets for histone modifiers depend on their interacting transcription factors.

The tri-methylation of H3K27 (H3K27me3) of a certain gene is determined by the balance between the Polycomb Repressive Complex 2 (PRC2) and histone demethylases JMJD3 and UTX ([@b1-molcell-37-1-43-7]). H3K27me3 and H3K9me3 on the promoter and enhancer region are generally associated with the transcriptional inactivation, whereas H3K4me3 and the acetylation of H3K27 are associated with the transcriptional activation. A subset of promoters marked with both H3K4me3 and H3K27me3 is also known as bivalent promoters ([@b4-molcell-37-1-43-7]). The bivalent promoters are inactive but able to drive the gene expression with the loss of H3K27me3 and gain of H3K27Ac.

[@b11-molcell-37-1-43-7] showed that in macrophages JMJD3 can be induced by inflammatory stimuli such as lipopolysaccharide (LPS) and interferon (IFN)-γ. JMJD3 is highly expressed in differentiating bone marrow cells, while it is repressed in terminally differentiated macrophages. Upon treat-ment with LPS or IFN-γ, activated nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) occupies the promoter region of *JMJD3* and increases its transcription. LPS-induced JMJD3 activates a subset of genes by reducing the levels of the repressive histone mark H3K27me3. In macrophages, Bone morphogenetic protein 2 (Bmp-2) is one of the targets of JMJD3. The promoter of the *Bmp-2* gene contains a bivalent chromatin domain with high levels of both H3K4me3 and H3K27me3. LPS-induced JMJD3 demethylates H3K27me3 of the bivalent *Bmp-2* promoter to increase the transcription of Bmp-2.

The locus of inhibitor of cyclin-dependent Kinase 4a/Alternative Reading Frame (*INK4a/ARF*) has been identified as a target of JMJD3. Mouse *Ink4a/Arf* locus encodes p16^INK4a^, p15 ^INK4b^, and p19^ARF^. Both p16^Ink4a^ and p15^Ink4b^ inhibit CDK4/6 kinases leading to the activation of retinoblastoma (Rb) protein, whereas p19^Arf^ (p14^Arf^ in human) inhibits mouse double minute 2 homolog (MDM2) leading to the activation of p53. Therefore, the activation of *INK4a/ARF* locus triggers cellular senescence and apoptosis. In young proliferating cells, the promoter regions of *INK4a* and *ARF* genes are repressed with H3K27me3 marks, whereas in senescent cells this locus is activated by the loss of H3K27me3 marks. The expression of the oncogene H-RAS^V12G^ or Δ B-RAF contributes to the rapid induction of JMJD3 through the signal cascade of RAS-RAF-MEK-ERK-AP-1, leading to the demethylation of H3K27me3 on the *INK4a/ARF* locus ([@b2-molcell-37-1-43-7]; [@b3-molcell-37-1-43-7]).

Together with these findings, our study suggests that the expression of JMJD3 is regulated by many different transcription activators, including AP-1, NF-κB, and HIF-1α that are activated by senescence, inflammatory signals, hypoxia, and nonhypoxic HIF-1α activators. Therefore, hypoxia-induced JMJD3 can influence the demethylation of JMJD3 target genes such as *Bmp-2, INK4A, ARF*, and late *HoxA* genes such as *HoxA7* and *HoxA11*.
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![HIF-1α-dependent hypoxic induction of the mouse JMJD3 gene. (A--C) NIH-3T3 cells, and MEF were incubated under hypoxia (\< 0.5% O~2~) for 48 h. 3T3-L1 cells were incubated under hypoxia (\< 0.5% O~2~) for 36 h. The relative mRNA levels of BNIP3 and JMJD3 were analyzed by qRTPCR and normalized by 18S ribosomal RNA. The mean value of qRT-PCR from normoxic cells was set to 1. The data represent the average and standard deviations of triplicate measurements from qPCR. (D, E) HIF-1α knockdown 3T3-L1 cells and control 3T3-L1 cells were treated with hypoxia for 16 h; (D) qRT-PCR was performed using the primer sets for the indicated mouse genes; (E) Western blot analyses were performed by using the indicated antibodies and lysates from hypoxia treated mouse 3T3-L1 cells. HSP70 and β-Actin protein were used as the loading control. The results of two independent experiments were shown. The numbers indicated the relative intensity of each band which was measured using LAS-3000 luminescent image analyzer and Multi Gauge ver.3.0 imaging software. (F, G) 3T3-L1 cells were treated with DFN (100 μM), CoCl~2~ (200 μM), or hypoxia for 48 h; (F) Western blot analyses were performed using the indicated antibodies; (G) The RT-PCR analyses of JMJD3 and BNIP3 are shown. The 18S ribosomal RNA was used as the loading control. N, normoxia; H, hypoxia (\< 0.5% O~2~). The *p*-values were obtained using the Student's *t*-test and the significance between the groups is indicated (^\*\*^*p* \< 0.05, ^\*^*p* \< 0.1).](molcell-37-1-7-f1){#f1-molcell-37-1-43-7}

![Arnt-dependent hypoxic induction of the mouse JMJD3 gene. (A, B) Hepa1c1c7 cells and BpRc1 cells were incubated under hypoxia (\< 0.5% O~2~) for 16 h; (A) Western blot analyses were performed by using the indicated antibodies. The 14-3-3γ protein was used as the loading control; (B) The relative mRNA levels of mouse JMJD3 were analyzed by qRT-PCR. (C) The putative HREs in the mouse *JMJD3* gene are identified by using the MatInspector program ([www.genomatix.de](www.genomatix.de)) ([@b7-molcell-37-1-43-7]). The bars indicate the positions of the primer sets used for the ChIP analyses. The nucleotide sequences of putative HRE sites (−0.2 Kb, +3.9 Kb, +4.2 Kb) and flanking regions were shown (lower panel). (D) 3T3-L1 cells were incubated under hypoxia (\< 0.5% O~2~) for 16 h. ChIP analyses were performed with the indicated antibodies and primer sets of mouse JMJD3 and mouse Stra13 genes. Input values were obtained from samples treated in the same way as the experimental method, except that no immunoprecipitation steps were performed. The values on the y-axis are presented as the percentage input of the average and standard deviation of triplicate determinations of qPCR. (E) MEF were incubated under \< 0.5% O~2~, 3% O~2~, and 21% O~2~ (normoxia) for 48 h. ChIP analyses (upper panel) and Western blot analyses (lower panel) were performed using the indicated antibodies. N, normoxia; H, hypoxia (\< 0.5% O~2~). The *p*-values were obtained using the Student's *t*-test and the significance between the groups is indicated (^\*\*^*p* \< 0.05, ^\*^*p* \< 0.1).](molcell-37-1-7-f2){#f2-molcell-37-1-43-7}

![Hypoxic induction of human JMJD3 in hADSC. (A, B) hADSC were treated with hypoxia (\<0.5% O~2~, 48 h) or Clioquinol (50 μM, 16 h); (A) The relative mRNA levels of BNIP3 and JMJD3 were analyzed by qRT-PCR. The data represent the average and standard deviations of two independent experiments; (B) Western blot analyses were performed using the indicated antibodies. The results of two independent experiments were shown. The relative intensity of each band was measured as described in [Fig. 1E](#f1-molcell-37-1-43-7){ref-type="fig"}. (C) The putative HREs in the human *JMJD3* gene are identified as described in [Fig. 2C](#f2-molcell-37-1-43-7){ref-type="fig"}. The bars indicate the positions of the primer sets used for the ChIP analyses. The nucleotide sequences of putative HRE sites (−4.1 kb, −4.0 kb, −3.3 kb) and flanking regions were shown (lower panel). The *p*-values were obtained using the Student's *t*-test and the significance between the groups is indicated (^\*\*^*p* \< 0.05).](molcell-37-1-7-f3){#f3-molcell-37-1-43-7}

![ChIP analyses of the human *JMJD3* gene. hADSC were treated with hypoxia (\< 0.5% O~2~, 48 h) or Clioquinol (50 μM, 16 h). (A--F) ChIP analyses were performed using the indicated antibodies and primer sets for the human *JMJD3* gene; (A, C, and E) ChIP-eluted DNA was analyzed by PCR and visualized on 2% agarose gel electrophoresis. (B, D, and F) ChIP-eluted DNA was analyzed by qPCR. The values on the y-axis are presented as the percentage input of the average and standard deviation of triplicate determinations of qPCR. The primer set for the human *BNIP3*. promoter was used as the positive control. The *p*-values were obtained using the Student's *t*-test and the significance between the groups is indicated (^\*\*^*p* \< 0.05, ^\*^*p* \< 0.1).](molcell-37-1-7-f4){#f4-molcell-37-1-43-7}
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